Stock PROTAGONIST THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Protagonist Therapeutics Inc Nasdaq

Equities

US74366E1029

End-of-day quote Nasdaq
Other stock markets
- PTS - Intraday chart for Protagonist Therapeutics Inc
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Stock
  5. News Protagonist Therapeutics Inc
  6. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW